These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 7483284)
21. Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase. Le Grice SF; Panin M; Kalayjian RC; Richter NJ; Keith G; Darlix JL; Payne SL J Virol; 1991 Dec; 65(12):7004-7. PubMed ID: 1719238 [TBL] [Abstract][Full Text] [Related]
22. Structural requirements for enzymatic activities of foamy virus protease-reverse transcriptase. Schneider A; Peter D; Schmitt J; Leo B; Richter F; Rösch P; Wöhrl BM; Hartl MJ Proteins; 2014 Mar; 82(3):375-85. PubMed ID: 23966123 [TBL] [Abstract][Full Text] [Related]
23. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Morozov VA; Copeland TD; Nagashima K; Gonda MA; Oroszlan S Virology; 1997 Feb; 228(2):307-17. PubMed ID: 9123838 [TBL] [Abstract][Full Text] [Related]
24. The gene expression of human foamy virus does not require a post-transcriptional transactivator. Lee AH; Lee HY; Sung YC Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374 [TBL] [Abstract][Full Text] [Related]
25. Detection of rice tungro bacilliform virus gene products in vivo. Hay J; Grieco F; Druka A; Pinner M; Lee SC; Hull R Virology; 1994 Dec; 205(2):430-7. PubMed ID: 7526539 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Bieniasz PD; Rethwilm A; Pitman R; Daniel MD; Chrystie I; McClure MO Virology; 1995 Feb; 207(1):217-28. PubMed ID: 7871729 [TBL] [Abstract][Full Text] [Related]
27. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase. Gao HQ; Sarafianos SG; Arnold E; Hughes SH J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369 [TBL] [Abstract][Full Text] [Related]
28. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension. Goedken ER; Marqusee S Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase. Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458 [TBL] [Abstract][Full Text] [Related]
30. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase. Gao HQ; Boyer PL; Arnold E; Hughes SH J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880 [TBL] [Abstract][Full Text] [Related]
31. Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Zhang WH; Svarovskaia ES; Barr R; Pathak VK Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10090-5. PubMed ID: 12119402 [TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. Pfrepper KI; Rackwitz HR; Schnölzer M; Heid H; Löchelt M; Flügel RM J Virol; 1998 Sep; 72(9):7648-52. PubMed ID: 9696869 [TBL] [Abstract][Full Text] [Related]
33. Functional characterization of RNase H1 from Drosophila melanogaster. Filippov V; Filippova M; Gill SS Biochem Biophys Res Commun; 1997 Nov; 240(3):844-9. PubMed ID: 9398656 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone. Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994 [TBL] [Abstract][Full Text] [Related]
35. Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease. Pfrepper KI; Löchelt M; Schnölzer M; Flügel RM Biochem Biophys Res Commun; 1997 Aug; 237(3):548-53. PubMed ID: 9299401 [TBL] [Abstract][Full Text] [Related]
36. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing. Driscoll MD; Golinelli MP; Hughes SH J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281 [TBL] [Abstract][Full Text] [Related]
37. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization. Ghosh M; Jacques PS; Rodgers DW; Ottman M; Darlix JL; Le Grice SF Biochemistry; 1996 Jul; 35(26):8553-62. PubMed ID: 8679616 [TBL] [Abstract][Full Text] [Related]
38. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. Löchelt M; Flügel RM J Virol; 1996 Feb; 70(2):1033-40. PubMed ID: 8551561 [TBL] [Abstract][Full Text] [Related]
39. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase. Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360 [TBL] [Abstract][Full Text] [Related]
40. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Guo J; Wu W; Yuan ZY; Post K; Crouch RJ; Levin JG Biochemistry; 1995 Apr; 34(15):5018-29. PubMed ID: 7536033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]